Benjamin L Palleiko
CIK 1366244 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-11
Benjamin L Palleiko is a CHIEF EXECUTIVE OFFICER who has filed 64 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for KALV, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
64
-$5.69M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KALV | CHIEF EXECUTIVE OFFICER | 0 | $27.00 | $0 | -$5.71M | 56 | 2026-06-11 |
| ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Delisted | SVP & Chief Financial Officer | — | — | — | $0 | 2 | 2010-01-20 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | SVP, Corporate Dev. & CFO | 2,500 | — | — | $16.3K | 6 | 2008-06-18 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | KALV | Disp (D) | −479,989 | $0 | EDGAR |
| 2026-05-26 | KALV | Mixed | +12,324 | -$292.6K | EDGAR |
| 2026-05-19 | KALV | Mixed | +1,290 | -$30.2K | EDGAR |
| 2026-05-13 | KALV | Mixed | +3,798 | -$88.7K | EDGAR |
| 2026-04-20 | KALV | Mixed | +10,762 | -$193.1K | EDGAR |
| 2026-03-10 | KALV | Mixed | +8,932 | -$107.6K | EDGAR |
| 2026-02-24 | KALV | Mixed | +13,216 | -$156.2K | EDGAR |
| 2026-02-19 | KALV | Mixed | +1,381 | -$15.6K | EDGAR |
| 2026-02-13 | KALV | Mixed | +3,766 | -$52.7K | EDGAR |
| 2026-01-21 | KALV | Grant (A) | — | $0 | EDGAR |